🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

FDA (U.S. FDA) gives accelerated approval to Avmapki Fakzynja Co-pack (avutometinib capsules; defactinib tablets), making it the first FDA-approved treatment for recurrent low-grade serous ovarian cancer patients who have a KRAS mutation: bit.ly/43DI9pu. #GynCSM #LGSOC

OCRA offers gynecologic cancer patients a simple way to find clinical trials in the U.S. and Canada via our free one-stop service: ocrahope.org/clinicaltrial. Patients can search on their own, fill out an online form, or speak with someone directly. #ClinicalTrialsDay #GynCSM

A certain type of white blood cell can remember ovarian cancer cells, enabling more effective targeting of tumors, study says. These findings from researchers at Sweden’s @KarolinskaInst & colleagues hold promise for advancing immunotherapies. medicalxpress.com/news/2025-04-n…

OCRA Pres. & CEO Audra Moran delves into the organization’s evolution, thoughts on how AI may revolutionize ovarian cancer, and more in this wide-ranging interview on Out of Patients with Matthew Zachary (Matthew Zachary ✡️ 🇮🇱🟦). Listen at bit.ly/3ZzDIcZ. #OvarianCancer #GynCSM

Dr. Bisiayo Fashemi of Washington University in St. Louis (WashU) shares how her grant from OCRA reinforced her resolve to drive research forward. Learn more about OCRA-funded research and its impact at bit.ly/3SnC8ao. #CancerResearchMonth

No one should face gynecologic cancer alone. OCRA’s support programs, educational workshops & peer mentor connections can help you & your loved ones navigate diagnosis & beyond. Get more details about our free resources: bit.ly/44XPeT5 #MentalHealthAwarenessMonth #GynCSM

Global collaborative research push resonates across airwaves, plus new treatment approved & more: bit.ly/3Z6t3q2. #OvarianCancer #CancerResearch

Join Jennifer in spinning up support for the ovarian & gynecologic cancer community this #NationalBikeMonth. Sign up for a fitness event or start one of your own to raise funds for OCRA’s research, advocacy & support programs.⁠ Get details at bit.ly/4kgPRMa. #GynCSM

OCRA is here for all who have been impacted by uterine cancer, offering support & funding research to reduce disparities: bit.ly/453Mtjh #UterineCancer #UterineCancerAwarenessMonth

A free, updated resource for cervical cancer patients & caregivers offered by the National Comprehensive Cancer Network (National Comprehensive Cancer Network (NCCN)) & sponsored by OCRA is now available: bit.ly/4e4ulZ7. #CervicalCancer #GynCSM

Raise awareness about endometrial cancer risk. This simple action could save a life. Learn more at ocrahope.org/uterinecancer. #EndometrialCancer #UterineCancerAwarenessMonth

Molecular profiling holds promise for determining which #EndometrialCancer patients should receive radiotherapy to reduce recurrence risk and which patients can safely avoid it, says an international study involving Leiden University researchers & colleagues: medicalxpress.com/news/2025-05-m…